FDA blocks much-anticipated BioMarin hemophilia gene therapy

  • Home
  • FDA blocks much-anticipated BioMarin hemophilia gene therapy

FDA blocks much-anticipated BioMarin hemophilia gene therapy

Posted by The Analyst | August 19, 2020 | Politics

Investors fled drug developer BioMarin in droves on Wednesday, driving shares down by a third after U.S. regulators rejected the company’s potentially game-changing hemophilia A gene therapy over concerns it … Click to Continue »

Read more here:: FDA blocks much-anticipated BioMarin hemophilia gene therapy

      

Related Blogs

No Image
Posted by The Analyst | February 24, 2021
Top board leaders resign after deadly Texas power outages
Top board leaders of Texas' embattled power grid operator said Tuesday they will resign following outrage over more than 4 million customers losing electricity last week during a deadly winter...
60 Likes
No Image
Posted by The Analyst | February 24, 2021
Asian shares slip on jitters over inflation, interest rates
Shares fell Wednesday in Asia as investors weighed the possibility that inflation might prompt central banks to adjust their ultra-low interest rate policies. Hong Kong led the decline, losing 2%...
63 Likes
No Image
Posted by The Analyst | February 24, 2021
For Senate rules arbiter, minimum wage is latest minefield
She's guided the Senate through two impeachment trials, vexed Democrats and Republicans alike with parliamentary opinions and helped rescue Electoral College certificates from a pro-Trump mob ransacking the Capitol. She...
44 Likes